Reduced P3a amplitudes in antipsychotic naïve first-episode psychosis patients and individuals at clinical high-risk for psychosis

Journal of Psychiatric Research

Volumn 47, Issue 6, 2013, Pages 755-761

  Mondragón Maya, Alejandra ^a   Solís Vivanco, Rodolfo ^a   León Ortiz, Pablo ^a   Rodríguez Agudelo, Yaneth ^a   Yáñez Téllez, Guillermina ^b   Bernal Hernández, Jorge ^b   Cadenhead, Kristin S ^c,d   de la Fuente Sandoval, Camilo ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Clinical high risk; Event related potentials; First episode psychosis; P3a; Schizophrenia

Indexed keywords

FLUOXETINE; SERTRALINE;

ADULT; AGE DISTRIBUTION; ARTICLE; BRIEF PSYCHOTIC DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EDUCATION; ELECTROENCEPHALOGRAM; EVENT RELATED POTENTIAL; FEMALE; HIGH RISK PATIENT; HUMAN; LATENT PERIOD; MALE; MARRIAGE; MISMATCH NEGATIVITY; OCCUPATION; PRIORITY JOURNAL; SCHIZOPHRENIFORM DISORDER; SEX DIFFERENCE;

EID: 84875895440     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.12.017     Document Type: Article

References (73)

1. Addington J., Cornblatt B., Cadenhead K., Cannon T., McGlashan T., Perkins D., et al. At clinical high risk for psychosis: outcome for nonconverters. American Journal of Psychiatry 2011, 168:800-805.
2. Alho K., Woods D., Algazi A., Knight R., Näätänen R. Lesions of frontal cortex diminish the auditory mismatch negativity. Electroencephalography and Clinical Neurophysiology 1994, 91:353-362.
3. Atkinson R., Mitchie P., Schall U. Duration Mismatch Negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis. Biological Psychiatry 2012, 71:98-104.
4. Bodatsch M., Rurhmann S., Wagner M., Müller R., Schultze-Lutter F., Frommann I., et al. Prediction of psychosis by Mismatch Negativity. Biological Psychiatry 2010, 69:959-966.
5. Bozikas V., Andreou C., Giannakou M., Tonia T., Anezoulaki D., Karavatos A., et al. Deficits in sustained attention in schizophrenia but not in bipolar disorder. Schizophrenia Research 2005, 78:225-233.
6. Bramon E., Shaikh M., Broome M., Lappin J., Bergé D., Day F., et al. Abnormal P300 in people with high risk of developing psychosis. NeuroImage 2008, 41:553-560.
7. Brockhaus-Dumke A., Tendolkar I., Pukrop F. Impaired mismatch negativity generation in prodromal subjects and patients with schizophrenia. Schizophrenia Research 2005, 73:297-310.
8. Cannon T.D., Cadenhead K., Cornblatt B., Woods S.W., Addington J., Walker E., et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Archives of General Psychiatry 2008, 65:28-37.
9. Cortiñas M., Corral M., Garrido G., Garolera M., Pajares M., Escera C. Reduced novelty-P3 associated with increased behavioral distractibility in schizophrenia. Biological Psychology 2008, 78:253-260.
10. de la Fuente-Sandoval C, León-Ortiz P, Azcárraga M, Favila R, Stephano S, Graff-Guerrero A. Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study. International Journal of Neuropsychopharmacology ; in press, doi:10.1017/S1461145712000314:.
11. Deouell L., Knight R. Executive function and higher-order cognition: EEG studies. Encyclopedia of Neuroscience 2009, 105-109. Academic Press, Oxford. L. Squire (Ed.).
12. Devrim-Ucok M., Keskin-Ergen H.Y., Ucok A. Mismatch negativity at acute and post-acute phases of first-episode schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 2008, 258:179-185.
13. Duncan C.C., Barry R.J., Connolly J.F., Fischer C., Michie P.T., Naatanen R., et al. Event-related potentials in clinical research: guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400. Clinical Neurophysiology 2009, 120:1883-1908.
14. Escera C., Alho K., Schröger E., Winkler I. Involuntary attention and distractibility as evaluated with event-related brain potentials. Audiology & Neuro-otology 2000, 5:151-166.
15. Escera C., Corral M. Role of mismatch negativity and novelty-P3 in involuntary auditory attention. Journal of Psychophysiology 2007, 21:251-264.
16. First M.B., Spitzer R.L., Williams J.B., Gibbon M. Structured clinical interview for DSM-IV disorders (SCID) 1997, American Psychiatric Association, Washington, DC.
17. Freedman D., Brown A. The developmental course of executive functioning in schizophrenia. International Journal of Developmental Neuroscience 2011, 29:237-243.
18. Friedman D., Cycowicz Y., Gaeta H. The novelty P3a: an event related brain potential (ERP) sign of the brain's evaluation of novelty. Neuroscience and Biobehavioral Reviews 2001, 25:355-373.
19. Frommann I., Brinkmeyer J., Ruhrmann S., Hack E., Brockhaus-Dumke A., Bechdolf A., et al. Auditory P300 in individuals clinically at risk for psychosis. International Journal of Psychophysiology 2008, 70:192-205.
20. Fusar-Poli P., Borgwardt S., Crescini A., Deste G., Kempton M., Lawrie S., et al. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neuroscience and Biobehavioral Reviews 2011, 35:1175-1185.
21. Fusar-Poli P., Broome M., Woolley J., Johns L., Tabraham P., Bramon E., et al. Altered brain function directly related to structural abnormalities in people at ultra high risk of psychosis: longitudinal VBM-fMRI study. Journal of Psychiatric Research 2011, 45:190-198.
22. Fusar-Poli P., Byrne M., Valmaggia L., Day F., Tabraham P., Johns L., et al. Social dysfunction predicts two years clinical outcome in people at ultra high risk for psychosis. Journal of Psychiatric Research 2010, 44:294-301.
23. Garcia-Garcia M., Barceló F., Clemente I., Escera C. COMT and ANKK1 gene-gene interaction modulates contextual updating of mental representations. NeuroImage 2011, 56:1641-1647.
24. Green M.F., Nuechterlein K.H. Cortical oscillations and schizophrenia: timing is of the essence. Archives of General Psychiatry 1999, 56:1007-1008.
25. Hermens D.F., Ward P.B., Hodge M.A., Kaur M., Naismith S.L., Hickie I.B. Impaired MMN/P3a complex in first-episode psychosis: cognitive and psychosocial associations. Progress in Neuropsychopharmacology and Biological Psychiatry 2010, 34:822-829.
26. Jahshan C., Cadenhead K.S., Rissling A.J., Kirihara K., Braff D.L., Light G.A. Automatic sensory information processing abnormalities across the illness course of schizophrenia. Psychological Medicine 2012, 42:85-97.
27. Jasper H. The ten-twenty electrode system for the International Federation. Electroencephalography and Clinical Neurophysiology 1958, 10:371-375.
28. Javitt D.C., Shelley A., Ritter W. Associated deficits in mismatch negativity generation and tone matching in schizophrenia. Clinical Neurophysiology 2000, 111:1733-1737.
29. Jung W.H., Kim J.S., Jang J.H., Choi J.S., Jung M.H., Park J.Y., et al. Cortical thickness reduction in individuals at ultra-high-risk for psychosis. Schizophrenia Bulletin 2011, 37:839-849.
30. Kähkönen S., Ahveninen J., Pekkonen E., Kaakkola S., Huttunen J., Ilmoniemi R., et al. Dopamine modulates involuntary attention shifting and reorientation. An electromagnetic study. Clinical Neurophysiology 2002, 113:1894-1902.
31. Kaur M., Battisti R.A., Lagopoulos J., Ward P.B., Hickie I.B., Hermens D.F. Neurophysiological biomarkers support bipolar-spectrum disorders within psychosis cluster. Journal of Psychiatry and Neuroscience 2012, 37:313-321.
32. Korostenskaja M., Dapsys K., Siurkute A., Maciulis V., Ruksenas O., Kahkonen S. Effects of olanzapine on auditory P300 and mismatch negativity (MMN) in schizophrenia spectrum disorders. Progress in Neuropsychopharmacology and Biological Psychiatry 2005, 29:543-548.
33. Lencz T., Smith C., McLaughlin D., Auther A., Nakayama E., Hovey L., et al. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biological Psychiatry 2006, 59:863-871.
34. Light G.A., Braff D.L. Stability of mismatch negativity deficits and their relationship to functional impairments in chronic schizophrenia. American Journal of Psychiatry 2005, 162:1741-1743.
35. Luck S. An introduction to the event-related potential technique 2005, MIT Press, Cambridge.
36. Luck S., Gold J. The construct of attention in schizophrenia. Biological Psychiatry 2008, 64:34-39.
37. Marco-Pallarés J., Nager W., Krämer U., Cunillera T., Càmara E., Cucurell D., et al. Neurophysiological markers of novelty processing are modulated by COMT and DRD4 genotypes. NeuroImage 2010, 53:962-969.
38. McCarthy G., Luby M., Gore J., Goldman-Rakic P. Infrequent events transiently activate human prefrontal and parietal cortex as measured by fMRI. Journal of Neurophysiology 1997, 77:1630-1634.
39. Miller T.J., McGlashan T.H., Rosen J.L., Cadenhead K., Cannon T., Ventura J., et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophrenia Bulletin 2003, 29:703-715.
40. Mitchie P. What has MMN revealed about the auditory system in schizophrenia?. International Journal of Psychophysiology 2001, 42:177-194.
41. Näätänen R., Paavilainen P., Rinne T., Alho K. The mismatch negativity (MMN) in basic research of central auditory processing: a review. Clinical Neurophysiology 2007, 118:2544-2590.
42. Niendam T., Bearden C., Zinberg J., Johnson J., O'Brien J., Cannon T. The course of neurocognition and social functioning in individuals at ultra high risk for psychosis. Schizophrenia Bulletin 2007, 33:772-781.
43. Özgürdal S., Gudlowski Y., Witthaus H., Kawohl W., Uhl I., Hauser M., et al. Reduction of auditory event-related P300 amplitude in subjects with at-risk mental state for schizophrenia. Schizophrenia Research 2008, 105:272-278.
44. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003, 361:281-288.
45. Polich J. Updating P300: an integrative theory of P3a and P3b. Clinical Neurophysiology 2007, 118:2128-2148.
46. Riecher-Rössler A., Pflueger M., Aston J., Borgwardt S., Brewer W., Gschwandtner U., et al. Efficacy using cognitive status in predicting psychosis: a 7-year follow-up. Biological Psychiatry 2009, 66:1023-1030.
47. Ruhrmann S., Schultze-Lutter F., Salokangas R.K., Heinimaa M., Linszen D., Dingemans P., et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Archives of General Psychiatry 2010, 67:241-251.
48. Salisbury D.F., Shenton M.E., Griggs C.B., Bonner-Jackson A., McCarley R.W. Mismatch negativity in chronic schizophrenia and first-episode schizophrenia. Archives of General Psychiatry 2002, 59:686-694.
49. Sato Y., Yabe H., Todd J., Michie P., Shinozaki T., Sutoh T., et al. Impairment in activation of a frontal attention-switch mechanism in schizophrenic patients. Biological Psychology 2002, 62:49-63.
50. Schimmelmann B., Huber C., Lambert M., Cotton S., McGorry P., Conus P. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. Journal of Psychiatric Research 2008, 42:982-990.
51. Schröger E., Giard M., Wolff C. Auditory distraction: event related potential and behavioral indices. Clinical Neurophysiology 2000, 111:1450-1460.
52. Seidman L.J., Giuliano A.J., Meyer E.C., Addington J., Cadenhead K.S., Cannon T.D., et al. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Archives of General Psychiatry 2010, 67:578-588.
53. Shaikh M., Valmaggia L., Broome M., Dutt A., Lappin J., Day F., et al. Reduced mismatch negativity predates the onset of psychosis. Schizophrenia Research 2012, 134:42-48.
54. Shelley A.M., Ward P.B., Catts S.V., Michie P.T., Andrews S., McConaghy N. Mismatch negativity: an index of a preattentive processing deficit in schizophrenia. Biological Psychiatry 1991, 30:1059-1062.
55. Singh F., Mirzakhanian H., Fusar-Poli P., de la Fuente-Sandoval C., Cadenhead K.S. Ethical implications for clinical practice and future research in "at risk" individuals. Current Pharmaceutical Design 2012, 18:606-612.
56. Solís-Vivanco R., Ricardo-Garcell J., Rodríguez-Camacho M., Prado-Alcalá R., Rodríguez U., Rodríguez-Violante M., et al. Involuntary attention impairment in early Parkinson's disease: an event-related potential study. Neuroscience Letters 2011, 495:144-149.
57. Sorensen H.J., Mortensen E.L., Parnas J., Mednick S.A. Premorbid neurocognitive functioning in schizophrenia spectrum disorder. Schizophrenia Bulletin 2006, 32:578-583.
58. Stevens M., Calhoun V., Kiehl K. Hemispheric differences in hemodynamics elicited by auditory oddball stimuli. NeuroImage 2005, 26:782-792.
59. Takeshita S., Ogura C. Effect of the dopamine D2 antagonist sulpiride on event-related potentials and its relation to the law of the initial value. International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology 1994, 16:99-106.
60. Todd J., Michie P., Schall U., Karayanidis F., Yabe H., Näätänen R. Deviant matters: duration, frequency, and intensity deviants reveal different patterns of Mismatch Negativity reduction in early and late schizophrenia. Biological Psychiatry 2008, 63:58-64.
61. Todd J., Myers R., Pirillo R., Drysdale K. Neuropsychological correlates of auditory perceptual inference: a mismatch negativity (MMN) study. Brain Research 2010, 1310:113-123.
62. Umbricht D., Javitt D., Novak G., Bates J., Pollack S., Lieberman J., et al. Effects of clozapine on auditory event-related potentials in schizophrenia. Biological Psychiatry 1998, 44:716-725.
63. Umbricht D., Javitt D., Novak G., Bates J., Pollack S., Lieberman J., et al. Effects of risperidone on auditory event-related potentials in schizophrenia. International Journal of Neuropsychopharmacology 1999, 2:299-304.
64. Umbricht D., Krljes S. Mismatch negativity in schizophrenia: a meta-analysis. Schizophrenia Research 2005, 76:1-23.
65. Umbricht D.S., Bates J.A., Lieberman J.A., Kane J.M., Javitt D.C. Electrophysiological indices of automatic and controlled auditory information processing in first-episode, recent-onset and chronic schizophrenia. Biological Psychiatry 2006, 59:762-772.
66. Valkonen-Korhonen M., Purhonen M., Tarkka I.M., Sipila P., Partanen J., Karhu J., et al. Altered auditory processing in acutely psychotic never-medicated first-episode patients. Brain Research. Cognitive Brain Research 2003, 17:747-758.
67. Van der Stelt O., Lieberman J., Belger A. Auditory P300 in high-risk, recent-onset and chronic schizophrenia. Schizophrenia Research 2005, 77:309-320.
68. Van Tricht M., Nieman D., Koelman J., Van der Meer J., Bour L., De Haan E., et al. Reduced parietal P300 amplitude is associated with an increased risk for a first psychotic episode. Biological Psychiatry 2010, 68:642-648.
69. Wood S., Pantelis C., Velakoulis D., Yücel M., Fornito A., McGorry P. Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophrenia Bulletin 2008, 34:322-329.
70. Yung A., Phillips L., McGorry P. Prediction of psychosis, a step towards indicated prevention of schizophrenia. The British Journal of Psychiatry 1998, 172:14-20.
71. Yung A., Phillips L., Yuen H., McGorry P. Risk factors for psychosis in an ultra-risk group: psychopathology and clinical features. Schizophrenia Research 2004, 67:131-142.
72. Yung A.R., McGorry P.D. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophrenia Bulletin 1996, 22:353-370.
73. Yung A.R., Phillips L.J., Yuen H.P., Francey S.M., McFarlane C.A., Hallgren M., et al. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophrenia Research 2003, 60:21-32.